Freedom of Information request on the Distribution Plan for Educational Risk Materials for Glycopyrronium Bromide 1mg and 2mg Tablets (FOI 22/799)
Published 21 December 2023
© Crown copyright 2023
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-18-july-2022/freedom-of-information-request-on-the-distribution-plan-for-educational-risk-materials-for-glycopyrronium-bromide-1mg-and-2mg-tablets-foi-22799
FOI 22/799
20th July 2022
Dear
Thank you for your information request, dated 4th July 2022, where you asked for a copy of the Distribution Plan for Educational Risk Materials (HCP and Patient Alert Card for the Caregiver) for the following products:
- PL 20117 0094 + 0095 – Glycopyrronium Bromide 1mg and 2mg Tablets - Morningside
- PL 15764/0156 + 0157 – Glycopyrronium Bromide 1mg and 2mg Tablets – Strandhaven.
I am pleased to provide you with the information requested.
Please find the enclosed copies of the two corresponding distribution plans.
The Freedom of Information Act only entitles you to access to information – the information supplied is subject to Crown copyright, and there are some restrictions on its re-use. For information on the reproduction or re-use of MHRA information, please visit https://www.gov.uk/government/publications/reproduce-or-re-use-mhra-information/reproduce-or-re-use-mhra-information.
If you have a query about the information provided, please reply to this email.
Kind regards,
FOI Team